Tag: DCTs

Digital Tools and Platforms Required to Enable Hybrid Transition & Change Management Digital Tools and Platforms for Hybrid Transition & Change Management in Clinical Trials The transition towards hybrid and decentralized clinical trials represents one of the most significant evolutions in clinical research, particularly accelerated by the recent COVID-19 pandemic. This shift requires not only…

Read More “Digital Tools and Platforms Required to Enable Hybrid Transition & Change Management” »

Workflow and SOP Design to Operationalize Hybrid Transition & Change Management at Scale The evolution of clinical trials has been significantly influenced by the COVID-19 pandemic, showcasing the urgent need for innovative methodologies. A particularly prominent concept is the hybrid clinical trial model, which enhances traditional procedures by integrating decentralized approaches. This comprehensive tutorial delineates…

Read More “Workflow and SOP Design to Operationalize Hybrid Transition & Change Management at Scale” »

KRIs, KPIs and Dashboards to Monitor Hybrid Transition & Change Management Performance KRIs, KPIs and Dashboards to Monitor Hybrid Transition & Change Management Performance The transition of clinical trials from traditional formats to hybrid models represents a critical evolution in the landscape of pharma clinical trials. This article provides a comprehensive guide for clinical operations,…

Read More “KRIs, KPIs and Dashboards to Monitor Hybrid Transition & Change Management Performance” »

Case Studies: Hybrid Transition & Change Management That Improved Recruitment and Retention Case Studies: Hybrid Transition & Change Management That Improved Recruitment and Retention Decentralized and hybrid clinical trials are reshaping the landscape of pharmaceutical clinical trials by enabling greater flexibility in participant recruitment and retention. Realizing the full potential of hybrid models requires efficient…

Read More “Case Studies: Hybrid Transition & Change Management That Improved Recruitment and Retention” »

Patient-Centric Design Principles for Successful Hybrid Transition & Change Management Patient-Centric Design Principles for Successful Hybrid Transition & Change Management The transition from traditional clinical trial models to decentralized and hybrid clinical trials (DCTs) is reshaping the landscape of clinical research. Emphasizing patient-centric design principles is essential for successful implementation and change management. This article…

Read More “Patient-Centric Design Principles for Successful Hybrid Transition & Change Management” »

Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials Introduction to Hybrid and Decentralized Clinical Trials The landscape of clinical trials is evolving rapidly, with a significant shift towards hybrid and decentralized clinical trial models. These methodologies are designed to improve patient…

Read More “Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials” »

Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials In the evolving landscape of clinical research, the transition from traditional to decentralized and hybrid clinical trial models is crucial. Clinical trial management has become more complex due to diverse patient populations, technological…

Read More “Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials” »

How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations As the landscape of clinical trials evolves, the need for hybrid transition and change management strategies has become increasingly significant. With regulatory oversight from agencies…

Read More “How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations” »

How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations The design and implementation of hybrid transition and change management strategies in clinical trials have become increasingly relevant with the advent of decentralized clinical trials….

Read More “How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations” »

Hybrid Transition & Change Management in Practice: Step-by-Step Guide for Sponsors and CROs Hybrid Transition & Change Management in Practice: Step-by-Step Guide for Sponsors and CROs The landscape of clinical trials has undergone a significant transformation, driven by the need for adaptability and resilience in response to global challenges such as the COVID-19 pandemic. Hybrid…

Read More “Hybrid Transition & Change Management in Practice: Step-by-Step Guide for Sponsors and CROs” »